Controlbionics

1 known investors

Control Bionics develops non-invasive neural-signal and physiological-data technology that converts biosignals into decision-ready insights for clinical, rehabilitation, research, sports performance, and assistive communication use. Its products, including speech-generating and eye-gaze AAC devices, serve individuals, clinicians, and organizations and hold FDA, TGA, and CE clearances.